• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROGAV SYS PED.W/SA 15 A.PRECHAMBER; HYDROCEPHALUS VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROGAV SYS PED.W/SA 15 A.PRECHAMBER; HYDROCEPHALUS VALVES Back to Search Results
Model Number FV440T
Device Problem Obstruction of Flow (2423)
Patient Problem Failure of Implant (1924)
Event Type  Injury  
Manufacturer Narrative
(b)(4).When additional information is received a follow up report will be submitted.
 
Event Description
It was reported by the healthcare professional "after implanted for a period of time, the patient was checked back into the hospital for pressure adjustment.But it was found unable to adjust the pressure.The valve pressure data was maintained with the same as last time.The device was explanted.".
 
Manufacturer Narrative
The shunt system was received dry in a plastic bag.At the time of submission the progav valve was set to pressure setting of 3 cmh2o.The first step of our investigation is an optical inspection.We found scratches on the valve housing but did not detect any obvious deformations or other abnormalities.However, the measurement of the plane parallelism could detect a deformation, the valve is with -0.0330 mm slight outside the permissible tolerance (tol.0+/- 0.02mm).Deformations can impair the functionality of the brake function and also the adjustability of the valve.To proof the penetrability of the valve we have carried out a penetrability test.This test was carried out at a hydrostatic pressure of approximately 20-30 cmh2o in the direction of flow.The investigation has shown that the progav valve was not permeable.Our adjustment tests are carried out with the standard progav check mate and measurement tool.The valve is adjusted from 0 up to 20 cmh2o and down again in increments of 5cmh2o.It was found that it was not possible to adjust the valve to the specified pressures settings.To measure the braking force we have investigated the valve with a braking force apparatus.Here is the measured how much force must be exerted on the housing of the progav 2.0 valve to release the rotor to adjust the valve by the integrated magnets.The brake function could be proven correctly.However, the measurement of the braking force could not be investigated because it was not possible to adjust the valve.We want to point out that we received the valve dry.The investigation of dry items is not significant due to the affect dry deposits of liquor and blood can have on product performance.In spite of this, we still decided to investigate the valve in all possible manner as best as we can.In the visual inspection of the progav valve we could find has scratches but not deformation or abnormalities.However, the measurement of parallelism has found a deformation of the housing membrane.Next we tested the permeability of the valve.The investigation indicated that the valve was not permeable.To ensure the valve is adjust the valve from 0 cmh20 up to 20cmh2o and down again in the same way in steps of 5 cmh2o.It was not possible to adjust the valve from 0 up to 20 cmh2o.To proof if the brake function is full in place we carried out a brake function test.However, the measurement of the braking force could not be investigated because it was not possible to adjust the valve.In order to verify whether the valve was compromised by the known risks of hydrocephalus therapy , e.G.By the build-up of natural substances (protein, blood or tissue particles) in the cerebrospinal fluid, we have dismantled the valve.As expected, inside the valve we have found significant dried substances (likely protein).Based on the investigation result we can confirm that the valve was not adjustable.We suspect that the substantial dried deposits in the valve may have affected the functioning of the valve.At the time of the distribution there is no failure detectable with the valve.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV SYS PED.W/SA 15 A.PRECHAMBER
Type of Device
HYDROCEPHALUS VALVES
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8117217
MDR Text Key128856782
Report Number3004721439-2018-00284
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K103003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/29/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Model NumberFV440T
Device Catalogue NumberFV440T
Device Lot Number20027699
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/05/2018
Distributor Facility Aware Date12/11/2018
Device Age3 YR
Date Manufacturer Received12/11/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-